Background: Systemic sclerosis (SSc) is a multisystem disorder characterized by thickening and fibrosis of skin, internal organs disease associated with vascular damage, premature aging of the arteries and activation of the immune system. The majority of SSc patients (pts) have autoantibodies (ab) against nuclear antigens. Among these, ab against topoisomerase I (topo I) are frequently detected in the serum of SSc pts. These ab are immunoglobulins reacting with a 70 kDA nuclear protein (Scl-70): an increasing of these is correlated with a poor prognosis. Aim of our study was to correlate arterial stiffness parameters, evaluated by echo-tracking, a new software provided by Aloka (Japan), and increase of serum levels of Scl-70 ab in SSc pts.
